Drugs / NXL103
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00949130 | Nov 2009 → Mar 2010 | — | Novexel Inc | Completed | No outcome recorded |
| Phase 2 | NCT00653172 | Oct 2007 → Jun 2008 | — | Novexel Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NXL103 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00653172 ↗ |
| Route | Oral | “600mg orally twice daily” NCT00653172 ↗ |